Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C413652-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $325.90 | |
C413652-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $543.90 | |
C413652-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $924.90 | |
C413652-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,665.90 | |
C413652-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $529.90 |
Calcium Channel Inhibitors
Synonyms | BS-15636 | CM 4620 | C73294 | BDBM50575336 | SCHEMBL18038390 | CS-0022201 | 564AW1RR37 | SB18686 | AC-35758 | CM4620 | CM-4620 | N-[5-(6-Chloro-2,2-difluoro-1,3-benzodioxol-5-yl)-2-pyrazinyl]-2-fluoro-6-methylbenzamide | HY-101942 | N-[5-(6-chloro-2,2-dif |
---|---|
Specifications & Purity | Moligand™, ≥99% |
Biochemical and Physiological Mechanisms | CM 4620 is an inhibitor of calcium-release activated calcium-channel (CRAC channel). CM4620 inhibits Orai1/STIM1-mediated Ca2+ currents and Orai2/STIM1-mediated currents with IC50 of near 120 nM and 900 nM, respectively. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | CHANNEL BLOCKER |
Mechanism of action | Channel blocker of Orai1;Channel blocker of Orai2 |
Product Description | Information CM 4620 CM 4620 is an inhibitor of calcium-release activated calcium-channel (CRAC channel) . CM4620 inhibits Orai1/STIM1-mediated Ca2+ currents and Orai2/STIM1-mediated currents with IC50 of near 120 nM and 900 nM, respectively. Targets Orai1/STIM1-mediated Ca2+ currents (Cell-free assay); Orai2/STIM1-mediated currents (Cell-free assay) 120 nM; 900 nM |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-2-fluoro-6-methylbenzamide |
---|---|
INCHI | InChI=1S/C19H11ClF3N3O3/c1-9-3-2-4-12(21)17(9)18(27)26-16-8-24-13(7-25-16)10-5-14-15(6-11(10)20)29-19(22,23)28-14/h2-8H,1H3,(H,25,26,27) |
InChi Key | QQMKTHUGOQDEIL-UHFFFAOYSA-N |
Canonical SMILES | CC1=C(C(=CC=C1)F)C(=O)NC2=NC=C(N=C2)C3=CC4=C(C=C3Cl)OC(O4)(F)F |
Isomeric SMILES | CC1=C(C(=CC=C1)F)C(=O)NC2=NC=C(N=C2)C3=CC4=C(C=C3Cl)OC(O4)(F)F |
Alternate CAS | 1713240-67-5 |
PubChem CID | 122507647 |
MeSH Entry Terms | Auxora;CM 4620;CM-128;CM-4620;CM128;CM4620;N-(5-(6-chloro-2,2-difluorobenzo(d)(1,3)dioxol-5-yl)pyrazin-2-yl)-2-fluoro-6-methylbenzamide;zegocractin |
Molecular Weight | 421.76 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C2425193 | Certificate of Analysis | Feb 19, 2024 | C413652 |
C2425194 | Certificate of Analysis | Feb 19, 2024 | C413652 |
C2425195 | Certificate of Analysis | Feb 19, 2024 | C413652 |
C2425196 | Certificate of Analysis | Feb 19, 2024 | C413652 |
C2425197 | Certificate of Analysis | Feb 19, 2024 | C413652 |
C2425198 | Certificate of Analysis | Feb 19, 2024 | C413652 |
C2425199 | Certificate of Analysis | Feb 19, 2024 | C413652 |
C2425200 | Certificate of Analysis | Feb 19, 2024 | C413652 |
C2425204 | Certificate of Analysis | Feb 19, 2024 | C413652 |
C2425205 | Certificate of Analysis | Feb 19, 2024 | C413652 |
Solubility | Solubility (25°C) In vitro DMSO: 100 mg/mL (237.1 mM); |
---|
Starting at $1,334.90
Starting at $1,334.90
1. Gerasimenko JV, Gryshchenko O, Ferdek PE, Stapleton E, Hébert TO, Bychkova S, Peng S, Begg M, Gerasimenko OV, Petersen OH. (2013) Ca2+ release-activated Ca2+ channel blockade as a potential tool in antipancreatitis therapy.. Proc Natl Acad Sci USA, 110 (32): (13186-91). [PMID:23878235] |
2. Gukovskaya AS, Pandol SJ, Gukovsky I. (2016) New insights into the pathways initiating and driving pancreatitis.. Curr Opin Gastroenterol, 32 (5): (429-435). [PMID:27428704] |